1. Signaling Pathways
  2. Immunology/Inflammation
  3. IRAK
  4. IRAK Inhibitors

IRAK Inhibitors

IRAK1

IRAK3

IRAK4

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

IRAK Inhibitors, Modulators, Degraders & Ligands
Product Name IRAK1 IRAK3 IRAK4 Purity
Zimlovisertib    
IRAK4, IC50: .2 nM
99.94%
KT-474    
IRAK4
99.77%
Ginsenoside Rb1
IRAK-1
    99.75%
AS2444697    
IRAK4, IC50: 21 nM
99.54%
Emavusertib    
IRAK4, IC50: 57 nM
99.97%
APH02174 hemiformic    
IRAK4
Zabedosertib    
IRAK4, IC50: 3.55 nM
98.22%
JH-X-119-01
IRAK-1, IC50: 9 nM
    99.65%
HS-276
IRAK1, IC50: 264 nM
 
IRAK4, IC50: 2500 nM
98.93%
KME-2780
IRAK1, IC50: 19 nM
 
IRAK4, IC50: 0.5 nM
98.94%
JNJ-1013
IRAK1, IC50: 72 nM
 
IRAK4, IC50: 443 nM
99.97%
AZ1495
IRAK1, IC50: 23 nM
 
IRAK4, IC50: 5 nM
98.07%
IRAK4-IN-4    
IRAK4, IC50: 2.8 nM
99.55%
JH-X-119-01 hydrochloride
IRAK1
    99.14%
Trimebutine
IRAK-1
    99.42%
Trimebutine maleate
IRAK-1
    99.66%
PROTAC IRAK4 degrader-1    
IRAK4
99.77%
KTX-951    
IRAK4, Kd: 3.5 nM
IRAK4, DC50: 18 nM
99.60%
IRAK1/4/pan-FLT3 Kinase-IN-1
IRAK-1, IC50: 5 nM
 
IRAK4, IC50: 0.6 nM
99.25%
IRAK4-IN-7    
IRAK4
99.36%
BIO-7488    
hIRAK4, IC50: 0.5 nM
99.44%
PROTAC IRAK4 degrader-3    
IRAK4
98.24%
Larotinib
IRAK1, IC50: 167 nM
    99.50%
HS-243
IRAK-1, IC50: 24 nM
 
IRAK4, IC50: 20 nM
99.95%
PROTAC IRAK4 degrader-13    
IRAK4
99.47%
IRAK4-IN-20    
IRAK4, IC50: 3.55 nM
PSP-0119    
IRAK4, IC50: 2.83 nM
98.65%
GLPG2534
IRAK1, IC50: 179 nM
 
hIRAK4, IC50: 6.4 nM
mIRAK4, IC50: 3.5 nM
98.73%
FIP22    
IRAK4, DC50: 3.2 nM
98.53%
IRAK4-IN-14    
IRAK4, IC50: 0.003 μM
99.01%
IRAK inhibitor 2    
IRAK4, IC50: <20 μM
99.19%
Larotinib mesylate hydrate
IRAK-1, IC50: 167 nM
    98.66%
PF-06426779    
IRAK4, IC50: 0.3 nM
99.89%
IRAK-4 protein kinase inhibitor 2    
IRAK4, IC50: 4 μM
98.07%
APH02174    
IRAK4, DC50: 4.01 nM
HS271    
IRAK4, IC50: 7.2 μM
99.92%
UR241-2
IRAK1
 
IRAK4
99.68%
IRAK inhibitor 4    
IRAK4
99.77%
Ginsenoside Rb1 (Standard)
IRAK-1
   
IRAK4 modulator-2
IRAK1, IC50: 0.97 μM
 
IRAK4, IC50: 0.005 μM μM
99.86%
GNE-2256    
IRAK4, Ki: 1.4 nM
99.14%
IRAK inhibitor 4 (trans)    
IRAK4
99.02%
Emavusertib hydrochloride    
IRAK4, IC50: 57 nM
IRAK4-IN-8    
IRAK4
IRAK4-IN-18    
IRAK4, IC50: 15 nM
GLPG4471    
IRAK4, IC50: 1.7 nM
PROTAC IRAK4 degrader-5    
IRAK4
Lomonitinib    
IRAK4
IRAK4-IN-16    
IRAK4, IC50: 2.5 ± 0.8 nM
PROTAC IRAK4 ligand-4    
IRAK4
HS-276 hydrochloride
IRAK1, IC50: 264 nM
 
IRAK4, IC50: 2500 nM
IRAK4-IN-9    
IRAK4, IC50: 1.5 nM
IRAK4-IN-10    
IRAK4, IC50: 1.5 nM
IRAK4-IN-13    
IRAK4, IC50: 0.6 nM
IRAK4-IN-31    
IRAK4
JH-l-25-NH2    
IRAK4
IRAK4 modulator-1    
IRAK4, IC50: 4.647 μM ([1])
99.11%
PROTAC IRAK3 degrader-2  
IRAK3, DC50: ≤ 50 nM
 
DW18134    
IRAK4, IC50: 11.2 nM
PROTAC IRAK4 degrader-2    
IRAK4
KTX-612    
IRAK4, DC50: 7 nM
AF-45
IRAK1, IC50: 1765 nM
 
IRAK4, IC50: 128 nM
BIO-8169    
IRAK4, IC50: 0.23 nM
GSI526    
IRAK4
PROTAC IRAK4 degrader-4    
IRAK4
BMS-986126    
IRAK4, IC50: 5.3 nM
KTX-497    
IRAK4, DC50: 3 nM
KTX-955    
IRAK4, IC50: 5 nM
IRAK4-IN-15    
IRAK4, IC50: 0.002 μM
IRAK4-IN-12    
IRAK4, IC50: 0.015 μM
IRAK4-IN-30    
IRAK4, IC50: 0.6 nM
IRAK4-IN-17    
IRAK4, IC50: 1.3 nM
PROTAC IRAK4 degrader-6    
IRAK4
IRAK4-IN-11    
IRAK4, IC50: .008 μM
IRAK4-IN-19    
IRAK4, IC50: 4.3 nM
HG-12-6    
IRAK4, IC50: 165 nM (Unphosphorylated inactive IRAK4 )
IRAK4, IC50: 2876 nM (Phosphorylated active IRAK4 )
HS-276 formic
IRAK1, IC50: 264 nM
 
IRAK4, IC50: 2500 nM
IRAK4 ligand-14    
IRAK4
PROTAC IRAK4 degrader-14    
IRAK4, DC50: 2.4 nM
IRAK4-IN-24    
IRAK4
IRAK4-IN-27    
IRAK4, IC50: 8.7 nM
Trimebutine-d3 hydrochloride
IRAK-1
   
IRAK1-IN-2
IRAK1
   
Trimebutine-d5 fumarate
IRAK-1
   
IRAK3 ligand-3  
IRAK3
 
BMS-978299    
IRAK4
Trimebutine maleate (Standard)
IRAK-1
   
IRAK4-IN-34    
IRAK4, IC50: 0.73 nM
Trimebutine (Standard)
IRAK-1
   
IRAK4-IN-32    
IRAK4